October 4 (SeeNews) - North Macedonia's biggest pharmaceutical company Alkaloid [MSE:ALK] said on Friday it will invest $1 million (906,534 euro) in South Korea's biotechnology company Rophibio, securing a stake and the right of first refusal for product licensing in its operating regions.